Latest debt-to-equity ratio

Larimar Therapeutics Debt-to-equity ratio

Direct answer

Larimar Therapeutics's debt-to-equity ratio is 3.89%.

The verified market snapshot reports 3.89%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 27, 2026.

Get free Larimar Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
3.89%